A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma.
about
Nucleic acid targeting: towards personalized therapy for head and neck cancer.Adenovirus 5 E1A enhances histone deacetylase inhibitors-induced apoptosis through Egr-1-mediated Bim upregulationDe-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells.Overview of the clinical efficacy of investigational anticancer drugs.Designing of 'intelligent' liposomes for efficient delivery of drugs.FOXO3a-Dependent Mechanism of E1A-Induced Chemosensitization.Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells.Advances in targeting IKK and IKK-related kinases for cancer therapyThe feasibility of gene therapy in the treatment of head and neck cancerA novel hTERT promoter-driven E1A therapeutic for ovarian cancer.The current state of head and neck cancer gene therapy.The anti-tumor activity of E1A and its implications in cancer therapy.Mussel-inspired PLGA/polydopamine core-shell nanoparticle for light induced cancer thermochemotherapy.Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.Interaction of Adenovirus E1A with the HHV8 Promoter of Latent Genes: E1A Proteins are Able to Activate the HHV-8 LANAp in MV3 Reporter CellsFolic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells.Inhibition of human non-small cell lung tumors by a c-Met antisense/U6 expression plasmid strategy.
P2860
Q26850237-B5E6BFEB-79D2-42D2-9789-49195DC3184DQ34200411-CFBB71CC-4AE8-4EFA-A5E0-5B2AB4C59DE6Q34786501-3F1C6C65-7D72-4DDA-85E4-DE46D115CD1CQ35067125-5748AAB7-0514-4B75-A5DA-23D8B2D7D01FQ35075383-5DC3A30A-C977-429D-9F35-3ECB396E75EFQ35622770-F612A6D8-EFD5-4858-AB69-4917C38593D9Q36393246-1567EC3E-2B0E-498C-9019-A95C6C907886Q37036746-3F015D9B-201E-4985-B1B6-CC81F1376212Q37093159-D7229717-3CFB-4450-B0FD-0850D61EFD7AQ37381467-BC3B656F-46B0-48D4-B4E6-493B304E7C18Q37595513-9A4AFA95-C2A5-4A49-A390-7B03C8294072Q38185905-8BFE99EA-23E1-48D0-A411-86CE33137BBAQ38688180-254A903A-420E-486F-9E8C-BE0BD0DACE48Q40493718-7E7BF4C5-7570-47C3-BD4E-6BB30E95143FQ41886930-ABF5A4DC-5FDF-4007-8BC8-55B1219A61A3Q42838745-2DA0882A-C8B8-4C57-8644-E361B0F3B2AAQ44737495-4D52EFA7-C32F-4AF7-ABBE-5154124A94B4
P2860
A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A multicenter phase II study o ...... neck squamous cell carcinoma.
@en
A multicenter phase II study o ...... neck squamous cell carcinoma.
@nl
type
label
A multicenter phase II study o ...... neck squamous cell carcinoma.
@en
A multicenter phase II study o ...... neck squamous cell carcinoma.
@nl
prefLabel
A multicenter phase II study o ...... neck squamous cell carcinoma.
@en
A multicenter phase II study o ...... neck squamous cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
A multicenter phase II study o ...... neck squamous cell carcinoma.
@en
P2093
Alison E Heald
Bonnie Glisson
Daniel Kenady
Doug Villaret
George H Yoo
Lyon Gleich
Mary Carey
Mien-Chie Hung
Neal Futran
Pervin Anklesaria
P2860
P304
P356
10.1002/HED.10107
P50
P577
2002-07-01T00:00:00Z